131 related articles for article (PubMed ID: 8491578)
1. Role of lipids in the progression of renal disease in chronic renal failure: evidence from animal studies and pathogenesis.
Shohat J; Boner G
Isr J Med Sci; 1993 Apr; 29(4):228-39. PubMed ID: 8491578
[TBL] [Abstract][Full Text] [Related]
2. Lipids and the progression of renal disease.
Keane WF; O'Donnell MP; Kasiske BL; Schmitz PG
J Am Soc Nephrol; 1990 Nov; 1(5 Suppl 2):S69-74. PubMed ID: 16989069
[TBL] [Abstract][Full Text] [Related]
3. Lipids in progression of renal disease.
Oda H; Keane WF
Kidney Int Suppl; 1997 Nov; 62():S36-8. PubMed ID: 9350676
[TBL] [Abstract][Full Text] [Related]
4. [Effect of a modified low protein and low fat diet on histologic changes and metabolism in kidneys in an experimental model of polycystic kidney disease].
Banković-Calić N; Ogbori MR; Nicman E
Srp Arh Celok Lek; 2002; 130(7-8):251-7. PubMed ID: 12585002
[TBL] [Abstract][Full Text] [Related]
5. Role of dietary lipids and renal eicosanoids on the progression of renal disease.
Klahr S; Harris K
Kidney Int Suppl; 1989 Nov; 27():S27-31. PubMed ID: 2699998
[TBL] [Abstract][Full Text] [Related]
6. Serum lipids in patients with chronic renal failure on long-term, protein-restricted diets.
Maschio G; Oldrizzi L; Rugiu C; Loschiavo C
Am J Med; 1989 Nov; 87(5N):51N-54N. PubMed ID: 2486548
[TBL] [Abstract][Full Text] [Related]
7. The role of lipid abnormalities in the pathogenesis of chronic, progressive renal disease.
Kasiske BL; O'Donnell MP; Schmitz PG; Keane WF
Adv Nephrol Necker Hosp; 1991; 20():109-25. PubMed ID: 2063707
[TBL] [Abstract][Full Text] [Related]
8. Lipids and renal disease.
Trevisan R; Dodesini AR; Lepore G
J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S145-7. PubMed ID: 16565240
[TBL] [Abstract][Full Text] [Related]
9. Progression of renal failure: role of apolipoprotein B-containing lipoproteins.
Attman PO; Samuelsson O; Alaupovic P
Kidney Int Suppl; 1997 Dec; 63():S98-101. PubMed ID: 9407433
[TBL] [Abstract][Full Text] [Related]
10. Effects of dietary polyunsaturated fatty acid supplementation in early renal insufficiency in dogs.
Brown SA; Brown CA; Crowell WA; Barsanti JA; Kang CW; Allen T; Cowell C; Finco DR
J Lab Clin Med; 2000 Mar; 135(3):275-86. PubMed ID: 10711867
[TBL] [Abstract][Full Text] [Related]
11. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
12. Effect of dietary manipulation on the lipid abnormalities in patients with chronic renal failure.
Maschio G; Oldrizzi L; Rugiu C; De Biase V; Loschiavo C
Kidney Int Suppl; 1991 Apr; 31():S70-2. PubMed ID: 2046274
[TBL] [Abstract][Full Text] [Related]
13. Lipids and progressive renal failure.
Keane WF
Wien Klin Wochenschr; 1996; 108(14):420-4. PubMed ID: 8784983
[TBL] [Abstract][Full Text] [Related]
14. The effect of n-3 fatty acids on lipids and lipoproteins in patients treated with chronic haemodialysis: a randomized placebo-controlled intervention study.
Svensson M; Schmidt EB; Jørgensen KA; Christensen JH
Nephrol Dial Transplant; 2008 Sep; 23(9):2918-24. PubMed ID: 18436564
[TBL] [Abstract][Full Text] [Related]
15. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
16. Genetic differences in susceptibility to glomerular sclerosis: a role for lipids?
Grond J; Muller EW; Weening JJ
Am J Med; 1989 Nov; 87(5N):30N-33N. PubMed ID: 2486543
[TBL] [Abstract][Full Text] [Related]
17. Increased susceptibility of LDL to in vitro oxidation in patients on maintenance hemodialysis: effects of fish oil and vitamin E administration.
Panzetta O; Cominacini L; Garbin U; Fratta Pasini A; Gammaro L; Bianco F; Davoli A; Campagnola M; De Santis A; Pastorino AM
Clin Nephrol; 1995 Nov; 44(5):303-9. PubMed ID: 8605710
[TBL] [Abstract][Full Text] [Related]
18. Special characteristics of atherosclerosis in chronic renal failure.
Amann K; Tyralla K; Gross ML; Eifert T; Adamczak M; Ritz E
Clin Nephrol; 2003 Jul; 60 Suppl 1():S13-21. PubMed ID: 12940530
[TBL] [Abstract][Full Text] [Related]
19. Role of lipids in the progression of renal disease in systemic lupus erythematosus patients.
Luzar B; Ferluga D
Wien Klin Wochenschr; 2000 Aug; 112(15-16):716-21. PubMed ID: 11020963
[TBL] [Abstract][Full Text] [Related]
20. Hyperlipidemia and renal disease: the use of animal models in understanding pathophysiology and approaches to treatment.
Stevenson FT; Kaysen GA
Wien Klin Wochenschr; 1999 Apr; 111(8):307-14. PubMed ID: 10378311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
